Scalability of Micro-Intraocular Implants and Devices
Scalability of Micro-Intraocular Implants and Devices Donna Bibber discusses some of these micro-intraocular implants and devices and the scalability challenges associated with each, from the perspective of a plastics engineer. Recent developments and new-to-market intra-ocular devices and implants have led to the successful treatment of a number of ophthalmological conditions of varying seriousness and complexity such as: Glaucoma Cataracts Retinal detachment Diabetic retinopathy Age-related macular degeneration Uveitis Dry-eye syndrome. Treatment of these conditions often requires collaboration between ophthalmological surgeons, pharmacologists, and micro-specific contract manufacturers. Development of these devices and implants occurs through a large number of highly focused, research-driven specialists, including and micro fabrication specialists, such as: Small, innovation-support funding programs Development companies that easily find a large marketing partner Big pharma funding the outsources of the development instead of…







